降压药物对脉搏波传导速度影响的差异及其与高敏C反应蛋白和假性血管性血友病因子的相关性
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Study on Difference of Various Antihypertensive Drugs on Pulse Wave Velocity and Correlation with High Sensitivity C-Reactive Protein and von Willebrand Factor
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的研究降压药物对单纯收缩期高血压患者脉搏波传导速度(PWV)影响的差异及其与高敏C反应蛋白(hs-CRP)和血浆假性血管性血友病因子(vWF)的相关性。方法选取单纯收缩期高血压病患者147例,所有入选患者至少停用或未服用降压药物时间达2周以上,血压符合收缩压(SBP)≥140 mmHg,舒张压(DBP)<90mmHg的要求。随机分成三组:硝苯地平控释片组(n=50)服用硝苯地平控释片30 mg/d;贝那普利组(n=49)服用贝那普利10 mg/d;缬沙坦组(n=48)服用缬沙坦80 mg/d。分别在用药前及用药后2周测量血压、臂踝脉搏波传导速度(Ba-PWV)及hs-CRP、vWF水平。结果治疗2周后,缬沙坦组Ba-PWV降低最明显,较贝那普利组和硝苯地平控释片组明显下降(P<0.01)。而硝苯地平控释片组收缩压(SBP)、舒张压(DBP)、脉压(PP)下降明显。同时缬沙坦组hs-CRP、vWF降低明显,贝那普利组次之。直线回归分析显示,缬沙坦组Ba-PWV下降与△SBP、△DBP及△PP均无明显相关性,但与△hs-CRP、△vWF呈强相关(r=0.96,p=0.02;r=0.67,p=0.01),贝那普利组次之,而硝苯地平控释片组△Ba-PWV与△SBP、△DBP及△PP相关(r=0.45,p=0.03;r=-0.27,p=0.02;r=0.75,p=0.00),与△hs-CRP和△vWF无明显的相关性。结论缬沙坦降低Ba-PWV、降低血管僵硬度的作用主要源于降压以外的抑制炎症反应、改善血管内皮功能。而硝苯地平控释片降低Ba-PWV、降低血管僵硬度的作用可能主要源于血压下降后对血管壁的牵拉力的下降。

    Abstract:

    Aim To investigate the effects of various antihypertensive drugs on pulse wave velocity(PWV) and study the correlation of effects with high sensitivity C-reactive protein(hs-CRP) and von Willebrand factor(vWF) in patients with isolated systolic hypertension. Methods 147 patients with isolated systolic hypertension were enrolled in this study and these patients' blood pressure fulfiled the criteria of systolic blood pressure(SBP) ≥140 mmHg and diastolic blood pressure(DBP) < 90 mmHg.These patients were devided radomly into nifedipine GITS group,benazeprilat group and valsartan group and were prescribed nifedipine GITS 30 mg/d,benazeprilat 10 mg/d and valsartan 150 mg/d respectively.Blood pressure,brachial-ankle pulse wave velocity(Ba-PWV),the levels of hs-CRP and vWF were measured at baseline and 2 weeks after treatment. Results Compared with nifedipine GITS group and benazeprilat group,Ba-PWV significantly decreased in valsartan group after 2 weeks(P<0.01),the level of Ba-PWV in nifedipine GITS group,benazeprilat group and valsartan group were-413.3±107.3 cm/s,-563.3±100.3 cm/s and-717.3±147.3 cm/s respectively.Compared with the other two groups,the levels of hs-CRP and vWF significantly decreased in valsar tan group(P<0.05),and the SBP,DBP and PP significantly decreased in nifedipine GITS group compared with the other two groups(P<0.05).Correlative study indicates the change of Ba-PWV in valsartan group was positively correlated with the change of hs-CRP and vWF(r=0.96,p=0.02;r=0.67,p=0.01),but not with the change of SBP,DBP and PP(P>0.05).And the change of Ba-PWV in the nifedipine GITS group was positively correlated with the change of SBP,DBP and PP(r=0.45,p=0.03;r=-0.27,p=0.02;r=0.75,p=0.00),but not with the change of hs-CRP and vWF(P>0.05).Conclusions Nifedipine GITS,benazeprilat and valsartan all can decrease Ba-PWV.However decreasing Ba-PWV and stiffness of vessel in alsartan group mainly originates from suppressesing inflammation and improving endothelial function,but the decrease of Ba-PWV in nifedipine GITS group mainly originates from the decrease of stretching pressure exerted by the blood against the vessel walls combined with expanding of artery.

    参考文献
    相似文献
    引证文献
引用本文

吴志勇,漆红梅,盛国太,周裔忠,李华泰.降压药物对脉搏波传导速度影响的差异及其与高敏C反应蛋白和假性血管性血友病因子的相关性[J].中国动脉硬化杂志,2011,19(8):693~696.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2010-12-06
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: